Skip to Main Content (Press Enter)

Logo CNR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNI-FIND
Logo CNR

|

UNI-FIND

cnr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at ?4?2 nicotinic acetylcholine receptor

Academic Article
Publication Date:
2017
abstract:
Each of the four aromatic -CH= of (S,R)-2-pyrrolidinyl-1,4-benzodioxane [(S,R)-6] and of its epimer at the dioxane stereocenter (S,S)-6, previously reported as ?4?2 nAChR ligands, was replaced with nitrogen. The resulting four diastereoisomeric pairs of pyrrolidinyl-pyridodioxanes were studied for the nicotinic affinity and activity at ?4?2, ?3?4 and ?7 nAChR subtypes and compared to their common carbaisostere. It turned out that such isosteric substitutions are highly detrimental, but with the important exception of the S,R stereoisomer of the pyrrolidinyl-pyridodioxane with the pyridine nitrogen adjacent to the dioxane and seven atoms distant from the pyrrolidine nitrogen. Indeed, this stereo/regioisomer not only maintained the ?4?2 affinity of [(S,R)-6], but also greatly improved in selectivity over the ?3?4 and ?7 subtypes and, most importantly, exhibited a highly selective ?4?2 partial agonism. The finding that [(S,R)-6] is, instead, an unselective ?4?2 antagonist indicates that the benzodioxane substructure confers affinity for the ?4?2 nAChR binding site, but activation of this receptor subtype needs benzodioxane functionalization under strict steric requirements, such as the previously reported 7-OH substitution or the present isosteric modification.
Iris type:
01.01 Articolo in rivista
Keywords:
Antagonism; Benzodioxane; Partial agonism; Pyridodioxane; ?3?4 nAChR; ?4?2 nAChR
List of contributors:
Gotti, Cecilia
Handle:
https://iris.cnr.it/handle/20.500.14243/358048
Published in:
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Journal
  • Overview

Overview

URL

https://www.ncbi.nlm.nih.gov/pubmed/27810599
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.5.0.0 | Sorgente dati: PREPROD (Ribaltamento disabilitato)